Global Cyber Lead

We are recruiting a for a global cyber lead - our most senior cyber role - to join the Information Systems Leadership Team. This role protects the integrity and operations of OXB systems and data from external, internal and inadvertent threats by designing and implementing a holistic risk-based approach to cyber security.

The role will collaborate closely with the Chief of Staff and consultant CIO for governance matters, the corporate risk team and of course the IT leadership for technical design and execution.,

• Lead the cyber strategy. Establish and maintain a holistic, risk-based approach to the cyber risk; considering all the threat-modes and mitigation actions; technical, governance and human-factors.


• Own the cyber framework. Establish and maintain a structure and systematic framework to capturing and manage the cyber risks..


• Monitor and report. Put in place systems to ensure compliance with the established framework and relevant regulation. Update Exec and Board directly.


• Run the Data Protection Group. Lead the governance forum responsible compliance and controls including GDPR.


• Track and advise on threat-landscape. Proactively develop an understanding of the external threat environment and inside risks and ensure that those risks are understood within the organisation.


• Lead the virtual cyber team. Work with business stakeholders, IT peers and other risk professionals (including internal audit) to drive actions and integration of cyber thinking throughout the business. There is no immediate plan to build out a big centralised cyber team separate from IT. [The role has dotted line to the CEO/CoS for influence and visibility.]


• Participate in operational IT planning. Contribute to the overall technology and infrastructure strategy and roadmap. Represent the needs of the cyber strategy including key areas of perimeter security, detection tools, disaster recovery and backup regime. Cyber is more than IT but IT is a big part of it.


• Act as Internal Audit for cyber. Oversee and assure general IT controls and compliance with procedures, in particular around elevated privilege management, insider risks and protection of configuration. Work directly with Corporate Risk team (in Finance) to achieve this.


• Drive awareness and education. Raise the general business skill level of the key cyber considerations - for end-users, system owners/designers and management. So that we design-in cyber thinking to everything.


• Represent IS and Cyber in corporate planning. Contribute directly to whole-business business continuity planning and disaster recovery activities. Representing the cyber requirements and being part of the response.


• Incident investigation. Investigate all adverse events, including near-misses, and ensure mitigating actions are put in place and where relevant that incidents are managed in the Quality Management Systems.


• Incident support. Play an advisory role in live incidents. Supporting the COO with the correct application of policies and procedures. Oversee incident management to ensure framework is applied.



• Reporting. Routine communication to stakeholders and upwards to Board. Escalate risks. Manage CET and Board communication during an incident.
  
  Proven experience as a cyber or similar leadership role in information security.


• Broad technical knowledge of IT operating environment - network, servers, endpoints, enterprise applications and security associated tools. Whilst this role has a "bias-towards management and non-technical aspects" this role demands technical understanding.


• Deep technical knowledge of defensive and responsive cyber security systems and tools.


• Helpful to have experience in GxP life sciences operations or similar QMS governed safety-critical environment; appreciation and understanding of regulatory compliance and how changes are made.


• Highly structured approach to understanding and addressing the cyber risks including strategic and practical experience of risk assessment methods, technologies and tools.


• Understanding of the latest security principles, techniques, and protocols.


• Familiarity with laws, regulations, and standards in information security


• Experience working with ISO 27001/2 or similar; whether formally qualified certificated or not
  
  We are a quality and innovation-led cell and gene therapy CDMO with a mission to enable our clients to deliver life changing therapies to patients around the world.


Our innovative solutions and proven expertise allow our clients in the biotech and biopharma industry, to deliver life-saving therapies to reach even more patients.

The success of cell and gene therapy products transforms outcomes for millions of people suffering from some of the world's worst diseases and medical conditions.

What's in it for you:


• Highly competitive total reward packages


• Wellbeing programmes


• Development opportunities


• A 35-hour working week


• Welcoming, friendly, supportive colleagues


• A diverse and inclusive working environment


• Our values are: Deliver Innovation, Be Inspiring and Have Integrity


• State of the art laboratory and manufacturing facilities


We want you to feel inspired every day. We're future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you.

Collaborate. Contribute. Change lives

We offer:

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise., Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient's cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients' cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at www.oxb.com, www.oxbsolutions.com, and follow us on LinkedIn, Twitter and YouTube.

Life at Oxford Biomedica

We value everyone's unique contribution, we appreciate everyone's individuality, and every job matters.

Your contributions are recognised and appreciated. Your work-life balance matters. We recognise, develop and use your strengths. It's a place where you are valued as a whole person, as an individual and as part of a team.

No matter who you are, or what you do, your work will make a significant difference.

We go the extra mile, every day, because we truly care. We work together as a team to achieve our life changing therapies. Our talented colleagues help to build other people's futures, so can you. We empower each other to be our best.

We have access to like-minded scientists and engineers, working in the latest technologies.

Our community of experts create new life-saving cures. Shaping the business' future through collaboration. Our people are on a continuous professional development journey aided by a thought-provoking environment. A place for experts to be stretched, and future experts to be nurtured. We inspire creativity and deliver great science, and so can you.

Our supportive culture invites talent, while creating future innovators.

We'll give you a place where you can learn, grow and contribute to the future of cell and gene therapy. We create opportunities and invest in our people, promoting ongoing learning. Our defined career pathways provide opportunities for everyone to achieve their career potential. We make a difference, and so can you.